uranium has been researched along with n,n',n'',n'''-tetra(1,2-dihydro-1-hydroxy-2-oxopyridine-6-carbonyl)-1,5,10,14-tetraazatetradecane in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ansoborlo, E; Archimbaud, M; Gourmelon, P; Henge-Napoli, MH; Metivier, H | 1 |
| Bailly, T; Burgada, R; Fritsch, P; Grillon, G; Ramounet-Le Gall, B; Rateau, G | 1 |
| Fukuda, S | 1 |
1 review(s) available for uranium and n,n',n'',n'''-tetra(1,2-dihydro-1-hydroxy-2-oxopyridine-6-carbonyl)-1,5,10,14-tetraazatetradecane
| Article | Year |
|---|---|
Chelating agents used for plutonium and uranium removal in radiation emergency medicine.
Topics: Animals; Aza Compounds; Catechols; Chelating Agents; Deferiprone; Diphosphonates; Emergency Medicine; Humans; Iron Chelating Agents; Pentetic Acid; Plutonium; Pyridones; Radiation Injuries; Uranium | 2005 |
2 other study(ies) available for uranium and n,n',n'',n'''-tetra(1,2-dihydro-1-hydroxy-2-oxopyridine-6-carbonyl)-1,5,10,14-tetraazatetradecane
| Article | Year |
|---|---|
Efficacy of 3,4,3-LIHOPO for reducing the retention of uranium in rat after acute administration.
Topics: Animals; Aza Compounds; Chelating Agents; Dose-Response Relationship, Drug; Injections, Intramuscular; Male; Pyridones; Rats; Rats, Sprague-Dawley; Uranium | 1995 |
Comparative decorporation efficacy of 3,4,3-LIHOPO, 4,4,4-LIHOPO and DTPA after contamination of rats with soluble forms of 238Pu and 233U.
Topics: Animals; Aza Compounds; Body Burden; Chelating Agents; Chelation Therapy; Decontamination; Dose-Response Relationship, Drug; Femur; Injections, Intravenous; Liver; Male; Pentetic Acid; Plutonium; Pyridones; Radiation Injuries; Rats; Rats, Sprague-Dawley; Treatment Outcome; Uranium; Whole-Body Counting | 2003 |